By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will commercialize Gen-Probe's Elucigene QST*R aneuploidy test kits under the Applied Biosystems name in certain markets around the world, the firm announced over the weekend.

Life Technologies will sell the test kits in Eastern Europe, Asia, Africa, Australia, Latin America, and Canada, under the agreement. However, the kits will not be available for sale in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.